Shares of Novo Nordisk edged up 0.2% to $254.30 on Oct. 10, a muted reaction to a potentially seismic development: the European Patent Office's Board of Appeal

Shares of Novo Nordisk edged up 0.2% to $254.30 on Oct. 10, a muted reaction to a potentially seismic development: the European Patent Office's Board of Appeal revoked patent EP 3 448 416, reversing its own preliminary opinion in a decision likely to have "far-reaching consequences." The ruling ac…